MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Andrew L. Pearlman, Ph.D., President and Chief Executive Officer of the Company, will deliver a corporate overview at the 24th Annual Roth Conference taking place March 11-14th at the Ritz Carlton in Dana Point, California. Dr. Pearlman will deliver his presentation on March 14th at 10:30 a.m. Pacific time.
